Green Sentry Holdings Completes Acquisition of MedMen’s Florida MMTC License and Assets
August 26th, 2022
News, Top News
Closes on $63 million (plus the assumption of lease liabilities in Florida) purchase of MedMen’s Florida assets, including MMTC license, 14 Premium Retail Dispensaries, 30,000 square foot Cultivation Facility, inventory and other assets
FORT LAUDERDALE, Fla., Aug. 26, 2022 /PRNewswire/ — Green Sentry Holdings, LLC (“Green Sentry” or “the Company”), a Florida-based private cannabis operator, along with its parent company High End Holdings, LLC and MedMen Enterprises Inc (“MedMen”) (CSE: MMEN) (OTCQX: MMNFF), a cannabis retailer with operations across the United States, today announced that they have completed their previously announced arrangement, whereby Green Sentry has acquired all of MedMen’s Florida assets for a total consideration of $63 million plus the assumption of lease liabilities. The purchase was funded with the proceeds of a non-brokered equity raise and a $30 million debt facility from a private lender.
The cash deal includes substantially all of MedMen’s Florida-based assets, including a valid medical marijuana treatment center license issued by the Florida Office of Medical Marijuana Use, a portfolio of 14 premium dispensaries in prime shopping locations with ample parking, and its Eustis, Florida cultivation and processing facility (“Eustis Facility”) with 30,000 square feet of available canopy. The Green Sentry team has been retrofitting the Eustis Facility since March of 2022, and in the coming months, edibles production is expected to launch.
On Friday, August 26, 2022, MedMen locations in Fort Lauderdale (2949 N Federal Hwy), Miami (550 Collins Ave), Orlando (11551 University Blvd), Pensacola (5048 Bayou Blvd), St. Petersburg (326 5th Ave North), West Palm Beach (539 Clematis St), and Tallahassee (1126 Thomasville Rd) will all reopen under Green Sentry’s management and new pricing will be unveiled as well. Store hours will be 10:00 am to 7:00 pm Monday through Saturday and 10:00 am to 5:00 pm on Sunday.
In addition to the ongoing expansion of the Company’s Florida footprint, Green Sentry will launch Sunburn Cannabis, a brand based on the true story of Green Sentry’s CEO and Founder Brady Cobb and his late father. Clyde Walton “Bill” Cobb’s story as a cannabis operator in the 70s and 80s is an authentic part of Florida’s cannabis history. Sunburn is a Florida-focused brand living at the intersection of top-shelf flower and concentrates while embracing the state’s unique culture. Green Sentry expects to launch the Sunburn Cannabis brand in the fourth quarter of 2022.
“As a team, we are beyond excited to re-enter the Florida market, where we have built a presence and a reputation for honoring the plant,” said Brady Cobb, CEO and Founder of Green Sentry. “It’s humbling to see my executive and operational teams stay together to close this transaction and launch Sunburn Cannabis. I’m incredibly proud to launch Sunburn and share my family’s passion and knowledge for the plant with people in Florida. Sunburn is a brand for Floridians by Floridians. I am also thrilled to add some key team members, including our Chairman and my good friend Danny Moses, as well as all of the MedMen employees who have joined our family. We have proven to the market previously that a Florida-focused company can produce the highest quality flower and concentrates, and now we are bringing our products to consumers via 14 of the best retail sites in Florida.”
“We are excited about the growth prospects of the Florida market and we believe in backing strong teams,” said Emily Paxhia, Managing Partner of cannabis-focused investment firm, Poseidon Asset Management. “The Sunburn team has experience coupled with deep knowledge of the market.”
Green Sentry’s cultivation and operations team began working on upgrades to the Eustis Facility in March 2022 and have already seen improvement in flower quality and yields. The Eustis Facility will soon increase HVAC capabilities; and install concrete floors, rolling benches, supplemental HPS lighting and an optimized fertigation system to further improve the quality of its flower. Green Sentry has secured a cultivation facility in Winter Garden, Florida which includes 27,000 sq ft of canopy in a Nexus Hybrid climate controlled Greenhouse plus a full GMP approved lab for hydrocarbon extraction, solventless extraction and the production of other derivative products (“Winter Garden“). Planned renovations for Winter Garden include the installation of supplemental HVAC, environmental controls and additional HPS lighting. Green Sentry also intends to break ground on an initial 75,000-square-foot indoor garden and processing facility at its property in Palm City, with plans to be fully operational by Q3 2023. The Palm City property can accommodate over 600,000 square feet of canopy, an essential addition as Florida licensees eye a potential adult-use constitutional amendment being added to the 2024 presidential ballot.
During the Transaction, Green Sentry was represented by Greg McLaughlin and the law firm of Tripp Scott, P.A. as well as Jeffrey Schlutz from Feuerstein Kulick LLP.
SOURCE Green Sentry Holdings, LLC
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.